Related Experiment Video
Updated: Jul 5, 2026
10:45
Stable Aqueous Suspensions of Manganese Ferrite Clusters with Tunable Nanoscale Dimension and Composition
Published on: February 5, 2022
Zinc ferrite nanoparticles as MRI contrast agents
Carlos Bárcena1, Amandeep K Sra, Girija S Chaubey
1Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Chemical Communications (Cambridge, England)
|May 9, 2008
Summary
Hydrophobic zinc iron oxide nanoparticles show enhanced MRI contrast capabilities. These nanoparticles improve T2 relaxivity and detection sensitivity compared to existing clinical agents.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Magnetic resonance imaging (MRI) contrast agents are crucial for medical diagnostics.
- Developing novel contrast agents with improved performance is an ongoing research area.
- Superparamagnetic iron oxide nanoparticles (SPIONs) are widely investigated for MRI applications.
Purpose of the Study:
- To synthesize and characterize novel hydrophobic zinc iron oxide (ZnxFe1-xO x Fe2O3) nanoparticles.
- To evaluate the potential of these nanoparticles as enhanced MRI contrast agents.
- To compare their performance against clinically used agents like Feridex.
Main Methods:
- Synthesis of mixed spinel ZnxFe1-xO x Fe2O3 nanoparticles with varying zinc content (x up to 0.34).
- Encapsulation of nanoparticles within polymeric micelles to impart hydrophobicity and stability.
- Assessment of T2 relaxivity and sensitivity of detection using MRI phantom studies.
Main Results:
- The synthesized ZnxFe1-xO x Fe2O3 nanoparticles demonstrated superparamagnetic properties.
- Encapsulation in polymeric micelles resulted in stable nanoparticle dispersions.
- The ZnxFe1-xO x Fe2O3 nanoparticles exhibited significantly higher T2 relaxivity compared to Feridex.
- Enhanced sensitivity of detection was observed with the novel nanoparticles.
Conclusions:
- Hydrophobic ZnxFe1-xO x Fe2O3 nanoparticles are promising candidates for advanced MRI contrast agents.
- These nanoparticles offer superior performance in terms of relaxivity and detection sensitivity.
- Further investigation is warranted for their clinical translation in MRI.
Related Concept Videos
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
01:14Imaging Studies I: CT and MRI
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...